Patients should be counseled that these symptoms, while uncomfortable, are generally not dangerous and tend to resolve over time
The SURMOUNT-1 trial (N=2,539), published in the New England Journal of Medicine in 2022 (DOI: 10.1056/NEJMoa2206038), evaluated tirzepatide at 5mg, 10mg, and 15mg weekly doses versus placebo in adults with obesity or overweight
Let me see what's happening with blood sugar, the A1C
Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, et al
Remember that your health today is foundational to your future longevity
It helps us feel full for longer and slows down the process of moving food from the stomach into the intestines, which is known as gastric emptying (1)